Tag: Paras Hospitals

Paras Hospitals Extends Medical Expertise in Gwalior with Launch of Super-Specialty OPD Services
Health

Paras Hospitals Extends Medical Expertise in Gwalior with Launch of Super-Specialty OPD Services

Jun 13, 2022 by Agency 0 Comments #Gwalior, #Paras Hospitals, #Super-Specialty OPD
Leading healthcare provider in Delhi-NCR, Paras Hospitals, Gurugram, today launched its exclusive super-specialty OPD services in Gwalior, in partnership with the city based Janak Superspecialty Hospital & Kain Cancer Care. The facility will provide expert advice and treatment in neurosurgery, Spine and complete Cancer Care. The super-speciality OPD which will be functional from today and the senior doctors will be available on every 3rd Wednesday of the month aiming to benefit the residents of Gwalior and its neighboring areas.
The OPD services were inaugurated in the honorable presence of Dr. (Prof.) Sumit Sinha, Director, Neuro and Spine Surgery, Paras Hospitals, Gurugram and Dr Rudra Prasad Acharya, Director, Surgical Oncology, Paras Hospitals, Gurugram, among various other eminent personalities, who were also present on the launch event. The OPD consultations will allow an ease of access for the local, thereby also drastically cutting down on travels for cancer and neuro related consults for both patients and their caregivers. Highly experienced and well qualified doctors from Paras Hospitals, Gurugram have already created their own milestones and are now inclined towards serving the society for ensuring better health.
Dr. (Prof.) Sumit Sinha addressed the masses and shed light on the growing incidence of neurological ailments including acute stroke, Brain tumor, head injury, disc prolapse, spine issue, neck and back pain and spine injury among many others, amongst people in tier II & tier III cities. “Awareness about the symptoms of neurological disorders and importance of timely intervention should be made more prominent among the masses. We would like to take this opportunity to sensitize the public about the importance of early detection and its role in the treatment outcomes. With recent advancements made in the field of neurosurgery, minimally invasive procedures for the treatment of Brain tumors have been emerging as one of the best methods of treatment.  Outreaching through the OPD services, the patients and local residents will be highly benefitted.” said Dr. (Prof.) Sumit Sinha, Director, Neuro and Spine Surgery, Paras Hospitals, Gurugram.
Dr. Rudra Acharya, Director, Surgical Oncology, Paras Hospitals, Gurugram said, “Incidence of cancer is growing across India and it is crucial for us to fight the challenge comprehensively. Our expertise and skilled team of doctors aim to implement new and advanced techniques to prioritize the best possible treatment. This effort is ultimately being taken to benefit the patients through advancements in cancer diagnosis and treatment. Having specialized units to provide personalized chemotherapy, and depending upon the type of treatment required, Patients with advanced cancers also find hope post treatment and disease management with improved quality of life. The rising burden of cancer certainly indicates that we need to create a series of awareness program for early detection and prevention of cancer. The good news is that any type of cancer is curable and patients can lead a normal life if detected early. I urge the masses to reach the right specialist at right time and don’t hesitate to discuss the word cancer among.”
Incidence of cancer is growing across India and it is crucial for us to fight the challenge comprehensively. For cancer patients, determination and the will to fight is half the battle won.  With state-of-the-art technology, specialized clinical approach and best in class diagnostic abilities, to combat the disease, the cancer centre is well equipped to spot even the most menial forms of cancer and at the same time, treat the most advanced cases.

 

cancer
News

Cancer Patients, Survivors Face New Challenges in the COVID 19 World

Aug 11, 2020 by Gouri Achary 0 Comments #Cancer Patients, #Chairman, #Dr R Ranga Rao, #Dr. Dharminder Nagar, #Gurugram., #Managing Director, #Paras Cancer Centre, #Paras Healthcare., #Paras Hospitals

Delhi NCR, 11 Aug 2020: As the world grapples with the COVID 19 pandemic, cancer patients, as well as cancer survivors, are facing particularly unique challenges, with a higher risk of complications from the viral disease, the need to manage their illness and mental health challenges affecting them disproportionately, say experts at leading healthcare provider Paras Healthcare.

With the disease as well as the treatment compromising the immunity of cancer patients and survivors, they face a heightened risk of a series of infections, COVID 19 being one of them. The evidence clearly suggests a higher rate of mortality from COVID 19 among people with cancer.

“Cancer patients and survivors are already dealing with a lot of difficulties. The COVID 19 crisis has only made it more challenging for them to manage their illness. Cancer patients and survivors are often immuno-compromised because of the disease or its treatment. A very critical element of disease management in them, therefore, is the need to safeguard them from all sorts of infections. People with compromised immune systems are not just at higher risk of contracting infections including COVID-19 but are also prone to severe complications from them. This translates into the need for additional precautions and care. Healthcare providers must adopt a comprehensive approach to the treatment of cancer patients during these times including ensuring the continuation of highest standards of care, unhindered treatment as well as psychological support,” said Dr. Dharminder Nagar, Managing Director, Paras Healthcare.

Cancer patients and their healthcare providers are facing a series of challenges during these times. Patients are worried about how to navigate their daily care, whether it is safe to continue visiting hospitals for chemotherapy or other sessions. They are also concerned about being de-prioritized as care receivers in the ‘new normal’. For patients whose treating hospitals have been converted into COVID 19 centres, there is a sudden crisis of how to continue receiving treatments.

“As cancer care providers, we have also grappled with several questions. For example, the pros and cons of starting or continuing chemotherapy at such a time because chemotherapy suppresses the immune system and makes patients more vulnerable to infections. On the other hand, stopping or delaying treatment puts cancer patients at greater risk of disease progression. Till now we have tried to ensure that no treatments are delayed or stopped. It is also extremely important to completely isolate the wards for cancer patients so that the risk of infection is minimized. At Paras Healthcare, we have been highly considerate of the needs of cancer patients and survivors. We have initiated special measures to ensure that they continue receiving highest standards of care while mitigating the risk of infection during treatment, diagnosis as well as imaging,” said Dr R Ranga Rao, Chairman, Paras Cancer Centre, Paras Hospitals, Gurugram.

An often overlooked aspect of cancer treatment is mental health management. The mental health of cancer patients takes a major hit even in normal circumstances. However, currently with a precarious disease situation, they are finding it extremely difficult to cope with the anxiousness and heightened risk of infection.

“We clearly see a rise in the incidence of anxiety and depression among cancer patients in the current circumstances. Offering psychological support, counselling, and medication support if needed to deal with mental health deterioration is important in these circumstances,” adds Dr. Rao.

Two studies published recently in The Lancet journal indicate a high rate of mortality among COVID-19 patients who also have cancer. In one of the studies, data from more than 900 COVID-19 and cancer patients from the US, Canada, and Spain showed a 13% mortality rate. Another study of 800 UK patients with COVID-19 and cancer found a 28% mortality. The studies also concluded that male patients with other COVID-19 mortality risk factors, such as older age and additional comorbidities, had an increased risk of death. However, cancer treatments such as chemotherapy did not appear to have an effect on mortality in either study.

Another study conducted in the US found that 10.4% of 1018 patients with cancer and COVID-19 had died between March and April. As compared to this, the mortality rate was 5.8% for each 100 confirmed cases.